Prosecution Insights
Last updated: October 25, 2026

Haukaas Fortius Pllc

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

19 pending office actions • 14 clients • 19 examiners • 18 art units • 0 of 19 (0%) have an AI response strategy ready

Analysis

Haukaas Fortius PLLC has 20 pending office actions in Biotechnology & Pharmaceuticals and 753 career applications. The record combines a defined active workload with a measurable application history.

The resolved allowance rate is 84.41%, and the average is 3.35 office actions per allowance. These measures provide separate views of resolved outcomes and the prosecution activity associated with allowances.

For a biotechnology client, the profile offers useful context for discussing both current docket management and historical examination experience. It does not show how results vary across applications or technical subfields.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=753 apps, methodology: how we score firms)

84.4%
Allowance Rate
n=753
+0.91σ
Allowance Rate (norm)
n=753
3.4
OAs to Allowance
n=352
-0.27σ
OAs to Allow (norm)
n=352
960 days
Time to Allowance
n=352
+15.4pp
Interview Lift
n=753
19.4%
RCE Rate
n=753
0.0%
Appeal Rate
n=753

Rejection Performance (% of received rejections ultimately overcome)

80.0%
§101 Overcome
n=35
76.5%
§102 Overcome
n=187
76.2%
§103 Overcome
n=265
78.6%
§112 Overcome
n=238

Specialization & Scale

A61K, A61P, C07D
Top CPC Subclasses
34%
Top-3 CPC Share
n=753
2
Practitioners
n=753
376.5
Apps / Practitioner
n=753

Portfolio Summary

19
Total Pending OAs
12
Non-Final OAs
5
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
2
Due this month
2
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (2)Due ≤ 60 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

13
Hard (68%)
6
Medium (32%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (11%)
§103 only4 (21%)
Double-patenting + other2 (11%)
Multi-statute (no §101)11 (58%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

16
Life Sciences
84% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
5% of docket
2
Mechanical / Eng
11% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

190 h
Manual time on pending OAs
38 h
Time saved (low, 20%)
66 h
Time saved (mid, 35%)
1.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
RAO, SAVITHA M 1 60.7% +29.7%
SUN, CAITLYN MINGYUN 1 63.7% +11.8%
OLADAPO, TAIWO 1 53.2% +11.8%
TRAN, LIEN THUY 1 28.7% +26.5%
WHITE, DAWANNA SHAR-DAY 1 62.4% +24.3%
WILLIS, DOUGLAS M 1 82.4% +19.7%
KIM, BOBBY YEONJIN 1 76.5% +20.7%
POTHEN, FEBA 1 81.0% +11.3%
NICKOL, GARY B 1 46.6% +33.3%
RITCHIE, HADEN MATTHEW 1 73.4% +33.8%

Hard Cases (13)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18633985 PHOTOIONIZATION DETECTOR POTHEN, FEBA 13d
18261373 ANTIBIOTICS WITH IMPROVED DRUG RESISTANCE PROFILE KIM, SEONG JONG 21d
16094791 ISOLATION OF PLANT EXTRACTS BOECKELMAN, JACOB A 53d
18548580 FABI INHIBITORS FOR GRAM-NEGATIVE PATHOGENS IVANOVA, SVETLANA M 54d
18914910 TUNABLE ELECTROOSMOTIC FLOW POLYMER COATED CAPILLARY SUN, CAITLYN MINGYUN —
18913376 METAL CARBIDE-BASED CATALYST SYSTEMS FOR PLASTIC RECYCLING OLADAPO, TAIWO —
18838803 COMPOSITION COMPRISING AN OLEOGEL AND A METHOD FOR PRODUCING A COMPOSITION COMPRISING AN OLEOGEL TRAN, LIEN THUY —
18710813 GRAM-NEGATIVE SPECIFIC ANTIBIOTICS SPARING EFFECT ON GUT MICROBIOME WILLIS, DOUGLAS M —

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18633985 PHOTOIONIZATION DETECTOR POTHEN, FEBA 13d
19163760 DRUG COMBINATION FOR TREATMENT OF PANCREATIC CANCER RAO, SAVITHA M —
18914910 TUNABLE ELECTROOSMOTIC FLOW POLYMER COATED CAPILLARY SUN, CAITLYN MINGYUN —
18913376 METAL CARBIDE-BASED CATALYST SYSTEMS FOR PLASTIC RECYCLING OLADAPO, TAIWO —
18838803 COMPOSITION COMPRISING AN OLEOGEL AND A METHOD FOR PRODUCING A COMPOSITION COMPRISING AN OLEOGEL TRAN, LIEN THUY —
18834350 IMIDAZOTETRAZINE COMPOUNDS AND TREATMENT OF TMZ-RESISTANT CANCERS WHITE, DAWANNA SHAR-DAY —
18710813 GRAM-NEGATIVE SPECIFIC ANTIBIOTICS SPARING EFFECT ON GUT MICROBIOME WILLIS, DOUGLAS M —
18708404 BAMBOO ELEMENTS AS LOAD-BEARING COMPONENTS AND T-BEAM ELEMENT AS CEILING ELEMENT, AND METHOD FOR PRODUCING A BAMBOO BLANK KIM, BOBBY YEONJIN —

Client Portfolio (14 clients)

Top Art Units

Art UnitApps
16272
16911
17951
17711
17931
16241
37251
28581
16431
37831

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19163760 DRUG COMBINATION FOR TREATMENT OF PANCREATIC CANCER Minneamrita Therapeutics LLC RAO, SAVITHA M 1691 §103 Non-Final OA — Pending Sep 09, 2025
18914910 TUNABLE ELECTROOSMOTIC FLOW POLYMER COATED CAPILLARY UNIVERSITY OF NOTRE DAME DU LAC SUN, CAITLYN MINGYUN 1795 §103§112 Non-Final OA — Pending Oct 14, 2024
18913376 METAL CARBIDE-BASED CATALYST SYSTEMS FOR PLASTIC RECYCLING Louisiana Tech Research Corporation OLADAPO, TAIWO 1771 §102§103 Non-Final OA — Pending Oct 11, 2024
18838803 COMPOSITION COMPRISING AN OLEOGEL AND A METHOD FOR PRODUCING A COMPOSITION COMPRISING AN OLEOGEL Perfat Technologies OY TRAN, LIEN THUY 1793 §101§102§103§112 Non-Final OA — Pending Aug 15, 2024
18834350 IMIDAZOTETRAZINE COMPOUNDS AND TREATMENT OF TMZ-RESISTANT CANCERS The Board Of Trustees Of The University Of Illinois WHITE, DAWANNA SHAR-DAY 1627 §102§103DP Non-Final OA — Pending Jul 30, 2024
18710813 GRAM-NEGATIVE SPECIFIC ANTIBIOTICS SPARING EFFECT ON GUT MICROBIOME The Board Of Trustees Of The University Of Illinois WILLIS, DOUGLAS M 1624 §102§112 Non-Final OA — Pending May 16, 2024
18708404 BAMBOO ELEMENTS AS LOAD-BEARING COMPONENTS AND T-BEAM ELEMENT AS CEILING ELEMENT, AND METHOD FOR PRODUCING A BAMBOO BLANK Clb Entwicklungsgesellschaft Mbh KIM, BOBBY YEONJIN 3725 §102§103§112 Non-Final OA — Pending May 08, 2024
18633985 PHOTOIONIZATION DETECTOR Alphasense Limited POTHEN, FEBA 2858 §102§103§112 Non-Final OA 13d Pending Apr 12, 2024
18580889 GENETICALLY ENGINEERED MULTIFUNCTIONAL EXOSOMES FOR IMMUNOTHERAPY UNIVERSITY OF SOUTHERN CALIFORNIA NICKOL, GARY B 1643 §102§112DP Non-Final OA — Pending Jan 19, 2024
18576658 METHOD AND APPARATUS FOR A STEADY STATE INTRAMUSCULAR INFUSION OF SEROTONERGIC DRUGS Psoulmed, LLC RITCHIE, HADEN MATTHEW 3783 §103 Final Rejection — Pending Jan 04, 2024
18568609 ELECTROCHEMICALLY-REGENERATED ION EXCHANGE USING REDOX-POLYMERS The Board Of Trustees Of The University Of Illinois KEYWORTH, PETER 1777 §102§103 Non-Final OA — Pending Dec 08, 2023
18548580 FABI INHIBITORS FOR GRAM-NEGATIVE PATHOGENS The Broad Institute, Inc. IVANOVA, SVETLANA M 1627 §102§103 Final Rejection 54d Pending Sep 01, 2023
18546472 CELL-FREE DNA METHYLATION TEST UNIVERSITY OF SOUTHERN CALIFORNIA JONES, CHRISTINE MICHELLE 1682 §101§102§103§112 Non-Final OA — Pending Aug 15, 2023
18263582 ENZYME INHIBITORS AND VIRAL INFECTION THERAPY UNIVERSITY OF SOUTHERN CALIFORNIA VAJDA, KRISTIN ANN 1622 §102§112 Non-Final OA — Pending Jul 31, 2023
18261373 ANTIBIOTICS WITH IMPROVED DRUG RESISTANCE PROFILE The Board Of Trustees Of The University Of Illinois KIM, SEONG JONG 1621 §102§103 Final Rejection 21d Pending Jul 13, 2023
18320485 NANO-HYPERBARIC WOUND HEALING THERAPEUTIC Revive Biotechnology, Inc. YU, HONG 1614 §103§112 Final Rejection — Pending May 19, 2023
17434217 PASTE FOR MARKING TEXTILE FABRICS AND/OR OTHER PRODUCTS INCAPABLE OF X-RAY CONTRAST Speed Care Mineral GmbH CRAIG, KAILA ANGELIQUE 1618 §103 Non-Final OA 3d overdue Pending Aug 26, 2021
17429299 MATERIALS AND METHODS FOR THE PREPARATION OF BACTERIAL CAPSULAR POLYSACCHARIDES The Regents of the University of California IANNUZO, NATALIE NMN 1653 §103 Non-Final OA 23d overdue Pending Aug 06, 2021
16094791 ISOLATION OF PLANT EXTRACTS Plant Extraction, LLC (A Georgia Limited Liability Company) BOECKELMAN, JACOB A 1655 §103§112 Final Rejection 53d Pending Oct 18, 2018

Managing Haukaas Fortius Pllc's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Haukaas Fortius Pllc's patent allowance rate?

84.4% of resolved applications prosecuted by Haukaas Fortius Pllc were allowed, across 753 applications in USPTO records.

How many office actions does Haukaas Fortius Pllc average before allowance?

3.35 office actions per allowed application on average.

How many pending office actions does Haukaas Fortius Pllc have?

19 pending office actions as of October 2026, for 14 clients, before 19 examiners in 18 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month